Triheptanoin in the treatment of long-chain fatty acid oxidation disorders (LC-FAOD)
Triheptanoin used to treat long-chain fatty acid oxidation disorders (LC-FAOD), a group of rare inherited disorders, in adults and children of all ages.
Documents
Details
For the full聽EAMS聽indication please see .
The scientific opinion includes:
- a public assessment report (PAR)
- a treatment protocol:
- for healthcare professionals
- for patients
- on the pharmacovigilance system
- Information for NHS Medical Directors